CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Fresenius Kabi USA LLC v. Claris Lifesciences Ltd.

1:14-cv-01498

Overview

Case Number 1:14-cv-01498
Filing Date 2014-12-19
Status Terminated
Termination Date 2015-04-17
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Claris Lifesciences Inc. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Claris Lifesciences Ltd. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Counter Claimant

Fresenius Kabi USA LLC Operating Company

Represented By

1 Attorneys Listed

Brian E. Farnan

Farnan LLP

Tel: +1 (302) 777-0300
Fax: +1 (302) 777-0301

919 North Market Street, 12th Floor

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 8 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts Counterparts in force
πŸ›οΈ
USPTO PTAB Trials 2 proceedings
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (8): πŸ‡ΊπŸ‡Έ US 🌐 PCT
Parallel Proceedings Across Jurisdictions (2 found):
PTAB: 2
USPTO PTAB Trial 2015-11-25
IPR2016-00254

Bass, J Kyle et al. v. Fresenius Kabi USA, LLC

Asserted Patent
Status: Final Written Decision
USPTO PTAB Trial 2015-02-06
IPR2015-00715

Dr. Reddy's Laboratories, Inc. et al. v. Fresenius Kabi USA, LLC

Asserted Patent
Status: Institution Denied
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US8476010
Propofol formulations with non-reactive container closures
Filed: 2003-07-10
Issued: 2013-07-02
Expired (Term Ended) +558d PTA
Expires: 2025-01-18

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Statutorily Barred

Statutorily Barred β€” Patent expired. Under 35 U.S.C. Β§ 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Scrutiny / Risk

High PTA (+558 days) / In re Cellect scrutiny applies.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).

Docket Entries

(10 total)
Pleading / Complaint

COMPLAINT filed against Claris Lifesciences Inc., Claris Lifesciences Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-1644230.) - filed by Fresenius Kabi USA LLC. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(dmp, ) (Entered: 12/19/2014)

Entry #1 • 2014-12-19
1
Pleading / Complaint

COMPLAINT filed against Claris Lifesciences Inc., Claris Lifesciences Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-1644230.) - filed by Fresenius Kabi USA LLC. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(dmp, ) (Entered: 12/19/2014)

Entry #1 • 2014-12-19
2
Pleading / Complaint

COMPLAINT filed against Claris Lifesciences Inc., Claris Lifesciences Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-1644230.) - filed by Fresenius Kabi USA LLC. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(dmp, ) (Entered: 12/19/2014)

Entry #1 • 2014-12-19
2

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (dmp, ) (Entered: 12/19/2014)

Entry #2 • 2014-12-19
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 11/4/2014. Date of Expiration of Patent: 06/01/2025.Thirty Month Stay Deadline: 5/4/2017. (dmp, ) (Entered: 12/19/2014)

Entry #3 • 2014-12-19
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc